Well I got a little preachy last week and I am really trying not to do that but inform, educate and engage in a dialogue that will hopefully bring about change. So I decided to go to the source with this next bit. As parents are faced with vaccinating their children, or opting out of that, HPV has been on the rise and of course parents must decide on what they want to do to in aid in keeping their children healthy.
Although I advocate for abstinence and married couple waiting until after they have married to have sex I know not everyone is going to do that....I especially feel sorry for the males who are made to feel like they NEED to know or do it so they can take care of their future wives or be successful with the ladies. Okay I'm stopping myself right there and here are the experts....
CDC: Vaccine can prevent 28,500 HPV-related cancer cases a year
CDC: Vaccine can prevent 28,500 HPV-related cancer cases a year
More than 30,000 cancers linked to human papillomavirus (HPV) are diagnosed each year
in the U.S., and most can be prevented by a vaccine, according to a new report.
“Increasing vaccination coverage could decrease the cancer incidence and disparities in the United States,” researchers from the Centers for Disease Control and Prevention (CDC) wrote in the report “Human Papillomavirus-Associated Cancers — United States, 2008-2012” published Thursday in the CDC’s Morbidity and Mortality Weekly Report, http://bit.ly/29ry5Ui.
HPV can cause cervical, vulvar, vaginal, penile, oropharyngeal, anal and rectal cancers. Roughly 38,793 HPV-associated cancers were diagnosed annually from 2008-’12, with about 59% affecting females, according to the CDC. The most common types were cervical carcinomas and oropharyngeal squamous cell cancers.
The annual average is up from about 33,369 a year in 2004-’08, although the increase is due in part to the inclusion of additional cancer sites.
Utah experienced the lowest rate in the most recent study with 7.5 cases per 100,000 people while Kentucky’s rate was highest at 14.7 per 100,000. There also were differences based on race and ethnicity. For example, cervical carcinoma rates were higher among blacks than whites and among Hispanics compared to non-Hispanics.
Of the 38,793 annual cancer cases associated with HPV based on their location and cell type, the CDC estimates 30,700 (79%) are attributable to HPV and 28,500 could be prevented with a 9-valent HPV vaccine.
The Academy and CDC recommend HPV vaccine as part of routine immunization for males and females at age 11 or 12 years, although it can be started as early as 9 years. They also recommend catch-up vaccination for females ages 13 to 26 and males 13 through 21 who have not been vaccinated or did not complete the three-dose series. Males ages 22 to 26 also should be vaccinated if they have sex with other men or are immunocompromised.
However, HPV vaccination rates have been lagging. Roughly 60% of female teens and 41.7% of male teens in the U.S. received at least one dose in 2014. Only 39.7% of the females and 21.6% of the males completed the three-dose series, according to the report.
In addition to recommending vaccination, the CDC stressed the importance of regular cervical cancer screenings.
“Most cervical cancers are preventable with regular screening for precancerous lesions among women aged 21-65 years linked with follow-up for abnormal test results,” researchers said.
“Increasing vaccination coverage could decrease the cancer incidence and disparities in the United States,” researchers from the Centers for Disease Control and Prevention (CDC) wrote in the report “Human Papillomavirus-Associated Cancers — United States, 2008-2012” published Thursday in the CDC’s Morbidity and Mortality Weekly Report, http://bit.ly/29ry5Ui.
HPV can cause cervical, vulvar, vaginal, penile, oropharyngeal, anal and rectal cancers. Roughly 38,793 HPV-associated cancers were diagnosed annually from 2008-’12, with about 59% affecting females, according to the CDC. The most common types were cervical carcinomas and oropharyngeal squamous cell cancers.
The annual average is up from about 33,369 a year in 2004-’08, although the increase is due in part to the inclusion of additional cancer sites.
Utah experienced the lowest rate in the most recent study with 7.5 cases per 100,000 people while Kentucky’s rate was highest at 14.7 per 100,000. There also were differences based on race and ethnicity. For example, cervical carcinoma rates were higher among blacks than whites and among Hispanics compared to non-Hispanics.
Of the 38,793 annual cancer cases associated with HPV based on their location and cell type, the CDC estimates 30,700 (79%) are attributable to HPV and 28,500 could be prevented with a 9-valent HPV vaccine.
The Academy and CDC recommend HPV vaccine as part of routine immunization for males and females at age 11 or 12 years, although it can be started as early as 9 years. They also recommend catch-up vaccination for females ages 13 to 26 and males 13 through 21 who have not been vaccinated or did not complete the three-dose series. Males ages 22 to 26 also should be vaccinated if they have sex with other men or are immunocompromised.
However, HPV vaccination rates have been lagging. Roughly 60% of female teens and 41.7% of male teens in the U.S. received at least one dose in 2014. Only 39.7% of the females and 21.6% of the males completed the three-dose series, according to the report.
In addition to recommending vaccination, the CDC stressed the importance of regular cervical cancer screenings.
“Most cervical cancers are preventable with regular screening for precancerous lesions among women aged 21-65 years linked with follow-up for abnormal test results,” researchers said.
- AAP HPV Champion Toolkit
- HPV vaccine implementation guidance
- HPV vaccine resources for health care professionals
- Tips for talking with parents about the HPV vaccine
- PediaLink continuing medical education courses (free): Adolescent Immunizations: Strongly Recommending the HPV Vaccine and Adolescent Immunizations: Office Strategies
- Information for parents about HPV
CDC says HPV-associated cancer cases on the rise in the US
A nurse holds up a vial and box for the HPV vaccine, brand name Gardasil, at a clinic in Kinston, N.C.
The report, published online Thursday in its Morbidity and Mortality Weekly Report, found a rise in HPV-associated cancers from 10.8 per 100,000 people from 2004 to 2008, to 11.7 per 100,000 people from 2008 to 2012, despite a slight decrease in the rate of cervical carcinoma. HPV-linked cancers consist of cancer of the cervix, vulva, vagina, penis, oropharynx, anus and rectum.
CDC researchers conducted the study because cancer registries don’t routinely collect information on HPV DNA presence in cancer tissues, and cancer cases associated with the virus defined by anatomic site and cell type include cancers not caused by HPV, according to a CDC news release. Thus, the number of cancer cases they attributed to HPV were only estimates.
Scientists analyzed data from qualified population-based cancer registries that cover about 99 percent of the U.S. population. They found that between 2008 and 2012, an average of nearly 39,000 HPV-associated cancers were diagnosed annually, including 23,000 among females and nearly 16,000 among males. Cervical carcinomas and oropharyngeal squamous cell carcinomas were the most common of these cancers.
“Most cervical cancers are preventable with regular screening for precancerous lesions among women aged 21–65 years linked with follow-up for abnormal test results,” researchers wrote in their paper, but “there are currently no effective population-based screening strategies for the other HPV-associated cancers.”
HPV-induced cancers now affecting a growing number of men
July 12, 2016 12:00 AMSoon thereafter he would be diagnosed with oropharyngeal cancer, a middle-throat cancer in the area of his tonsils. Such cancers traditionally involved tobacco use, but Dr. Wilson, 61, said he never smoked.
The fact is, Dr. Wilson’s cancer was caused by human papillomavirus or HPV, the same virus that causes cervical cancer in women.
It’s an example of the tide now turning on several fronts, with 80 percent of middle-throat head and neck cancers nowadays caused by HPV rather than smoking or alcohol, and more men getting HPV-associated head and neck cancers than women being diagnosed with HPV-associated cervical cancer.
“This has been a major blockbuster in the field with the growing number of head and neck cancers caused by HPV, which also causes cervical cancer,” said Julie Bauman, co-director of the UPMC Cancer Institute’s Head & Neck Cancer Center of Excellence and Dr. Wilson’s oncologist. “For the first time, there are more men with HPV-related cancer [of the head and neck] than women [with cervical cancer].”
HPV-associated head and neck cancers now are epidemic, she said, and “changing the face” of her clinic. Twenty years ago 80 percent of such cancers were linked to tobacco or alcohol use with HPV now responsible for that percentage.
“HPV long has been viewed as a women’s health issue, but now it’s a bona fide men’s health issue because they are on the front line of an epidemic, and this epidemic won’t peak for another generation,” Dr. Bauman said, noting the typical age of diagnosis being 40 to 60 years old.
The U.S. Centers for Disease Control and Prevention confirmed in a report Friday that more men now are being diagnosed with HPV-associated head and neck cancers (15,000) than women with HPV-based cervical cancers (11,000).
HPV is associated with oropharyngeal, rectal, anal, penile, vaginal and vulval cancers.
About 3,000 women also were diagnosed with head and neck cancers, with significantly more women than men still being diagnosed with HPV-associated anal and rectal cancers, along with the strictly female cancers. From 2008 to 2012, about 39,000 HPV-associated cancers were diagnosed annually with about 23,000 involving women and 16,000 involving males.
But the turnabout in gender results with head and neck vs. cervical cancers could convince parents to get their children immunized with the HPV vaccine, regardless of gender, with boys often overlooked because of the now-errant perception that the vaccine predominantly protects against cervical cancer.
A vast majority of people are infected with HPV in their teens or 20s as a result of the person’s first sexually intimate experience, given that the virus commonly is present in the area of the anus and genitals, Dr. Bauman said. For that reason, adolescents must receive the vaccine before their “sexual debut.”
Once a person is exposed to the virus or infected, it’s too late for the vaccine. While the virus is eliminated by the immune system in most people without ever causing a symptom, persistent infection does occur in a small percentage of people, raising their risk of HPV-based cancers later in life.
Dr. Wilson said his treatments were successful, despite his being unable to taste food, a sensation he hopes will return in time. He’s resumed working full time. Despite successful treatments, such cancers and their treatments including surgery, radiation and chemotherapy often take their toll on important human functions, including speaking, chewing, swallowing, breathing and facial expression.
He said he and Dr. Bauman have discussed plans to advocate to parents the need to have their adolescent sons and daughters vaccinated to prevent HPV-based cancers later in life. The CDC says only 40 percent of girls and 22 percent of boys currently receive all three doses of the vaccine.
“I think the vaccine is essential,” he said. “Every boy and girl of appropriate age needs the vaccine, and we need to stop them from having these cancers.”
Dr. Bauman agreed that the vaccine is a necessity. “I think it’s very important to destigmatize it and understand that HPV also is a men’s health issue, with men now on the front line of the epidemic.”
David Templeton: dtempleton@post-gazette.com or 412-263-1578.
No comments:
Post a Comment